Discovery and clinical evaluation of 1-{N-[2-(amidinoaminooxy)ethyl]amino}carbonylmethyl-6-methyl-3-[2,2-difluoro-2-phenylethylamino]pyrazinone (RWJ-671818), a thrombin inhibitor with an oxyguanidine P1 motif. (Q43184037)
Jump to navigation
Jump to search
scientific article published in February 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Discovery and clinical evaluation of 1-{N-[2-(amidinoaminooxy)ethyl]amino}carbonylmethyl-6-methyl-3-[2,2-difluoro-2-phenylethylamino]pyrazinone (RWJ-671818), a thrombin inhibitor with an oxyguanidine P1 motif. |
scientific article published in February 2010 |
Statements
Discovery and clinical evaluation of 1-{N-[2-(amidinoaminooxy)ethyl]amino}carbonylmethyl-6-methyl-3-[2,2-difluoro-2-phenylethylamino]pyrazinone (RWJ-671818), a thrombin inhibitor with an oxyguanidine P1 motif (English)
Tianbao Lu
Thomas Markotan
Shelley K Ballentine
Edward C Giardino
Carl S Crysler
Kathryn Brown
Bruce E Maryanoff
Bruce E Tomczuk
Bruce P Damiano
Umesh Shukla
David End
Patricia Andrade-Gordon
Roger F Bone
Mark R Player
1 February 2010